Clinical research - Press Releases

Date	Title	Company
04-Nov-2019	Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes	Sanofi
04-Nov-2019	Olympus SLIDEVIEW VS200 Solution with Reliable, Flexible, and High-Throughput Slide Scanning	Olympus
04-Nov-2019	Independent SMO Panthera Biopartners launches with its first clinical trial site in the UK	Panthera Biopartners
04-Nov-2019	Vifor Pharma enters into commercial collaboration in the US with Janssen	Vifor Pharma Group
04-Nov-2019	RedHill Biopharma Announces FDA Approval of Talicia® for Treatment of H. pylori in Adults	RedHill Biopharma Ltd
04-Nov-2019	Joining Forces – OPEN Health and Pharmerit International Merger	OPEN Health
01-Nov-2019	LPW Celebrates 15 Years Customizing Learning Solutions Worldwide	LPW Training Services
01-Nov-2019	A Closer Look at Biosensor Technology at Sensors USA 2019	Sensors USA
01-Nov-2019	UKCPA launch revised and updated Handbook of Perioperative Medicines	UK Clinical Pharmacy Association
31-Oct-2019	OB-002 Significantly Reduces Bone Metastasis in a Murine Model of Breast Cancer	Orion Biotechnology Canada, Ltd
31-Oct-2019	Vertex Announces European Medicines Agency Marketing Authorization Application Validation for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor Combination Treatment in Cystic Fibrosis	Vertex Pharmaceuticals
31-Oct-2019	RINVOQ™ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis	AbbVie
31-Oct-2019	The Alliance for Regenerative Medicine Outlines Recommendations for Increasing the Number of European-Based ATMP Clinical Trials	Alliance for Regenerative Medicine
31-Oct-2019	Aenitis Technologies and the Direction Générale de l'Armement (DGA) sign a partnership to develop a new AMSC-S project with a 1,2 million euros budget	AENITIS TECHNOLOGIES
31-Oct-2019	Biophytis Files Protocol Amendment to Optimize the SARA-INT Phase 2b Clinical Trial for Sarcopenia	Biophytis SA
31-Oct-2019	Bulletin from Moberg Pharma’s AGM on October 30th , 2019	Moberg Pharma
31-Oct-2019	Harley Street clinics to offer new brain stimulation treatment for depression	Flow Neuroscience
31-Oct-2019	First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar▼ for moderate-to-severe limbal stem cell deficiency (LSCD) caused by chemical or thermal eye burns	Chiesi UK
31-Oct-2019	Investigational Ebola Vaccine from Janssen and Bavarian Nordic to Support Outbreak Response in Democratic Republic of the Congo	Bavarian Nordic A/S
31-Oct-2019	Clinerion partners with PPC to bring Patient Network Explorer coverage and services to patients and hospitals in Korea, China and Taiwan.	Clinerion Ltd.